---
layout: minimal-medicine
title: Temozolomide
---

# Temozolomide
### Generic Name
Temozolomide

### Usage

Temozolomide is primarily an alkylating chemotherapy drug used to treat specific types of brain tumors. Its main application is in the treatment of newly diagnosed glioblastoma, a highly aggressive and common form of brain cancer.  It's also used to treat refractory anaplastic astrocytoma, a less common but equally serious brain tumor, in patients whose disease has progressed despite prior treatment with other chemotherapy regimens.  Importantly,  the use of Temozolomide in other cancers is considered off-label, meaning it's not officially approved for these conditions by regulatory agencies, although it may be used under a doctor's supervision in specific cases. These off-label uses include certain types of metastatic melanoma, pancreatic neuroendocrine tumors, primary CNS lymphoma, and some sarcomas.  Always consult with an oncologist to understand if Temozolomide is the appropriate treatment option for your specific case.


### Dosage

Temozolomide dosage is highly individualized and depends on several factors, including the specific cancer being treated, the patient's age, weight, and overall health, as well as their response to the treatment.  It is crucial to follow the precise instructions given by your doctor or healthcare provider.  There are significant variations in dosage based on whether the patient is an adult or a child, and also the specific type of cancer being treated. Dosages are often expressed as milligrams per square meter (mg/m²) of body surface area, a calculation that takes into account both height and weight.

**Adult Dosage:**  Dosage varies greatly depending on the indication (newly diagnosed glioblastoma vs. recurrent glioblastoma vs. other cancers).  The regimen involves daily oral administration for a specific number of days within a cycle, with cycles repeated every 28 days.  Doses are adjusted based on blood counts (particularly white blood cell and platelet counts) and the presence of side effects.  Specific dosage details for adults are complex and provided in the original document.  It's vital to consult a healthcare professional for the correct dosage.

**Pediatric Dosage:** Pediatric dosages are also complex and individualized and depend upon the specific condition being treated, weight and prior treatment. The dosages are often administered orally, and like adult regimens, are tailored to the individual child's response to treatment and the presence of side effects. Refer to a physician for appropriate dosage calculations.  Again, the specific dosage details are too intricate to list comprehensively here; consult the original document for the detailed dosage schedules provided for children.

**Important Note:**  This information is a summary.  The original document provides detailed, complex dosage instructions. Always follow the precise dosage and administration guidelines given by your healthcare provider.


### Side Effects

Temozolomide, like most chemotherapy drugs, can cause side effects.  The severity and frequency of these effects vary from person to person.  Common side effects (occurring in more than 10% of patients) may include:

* Nausea and vomiting
* Fatigue
* Alopecia (hair loss)
* Loss of appetite
* Constipation or diarrhea
* Low blood cell counts (leukopenia, neutropenia, thrombocytopenia, anemia)
* Dizziness
* Weakness


Less common but potentially serious side effects include:

* Allergic reactions (ranging in severity)
* Liver damage (hepatotoxicity)
* Lung problems (pneumonitis)
* Bone marrow suppression
* Increased risk of infection


If you experience any adverse effects, especially severe or unusual ones, it's vital to contact your doctor or healthcare provider immediately.


### How it Works

Temozolomide is a prodrug, meaning it's inactive when administered and needs to be converted into an active form within the body.  It's transformed into an active metabolite called MTIC (methyl-triazene-1-yl)-imidazole-4-carboxamide. This active form works by damaging the DNA of rapidly dividing cancer cells, preventing their replication and ultimately leading to their death.  This mechanism is non-cell cycle specific, meaning it can affect cells in various stages of division.


### Precautions

* **Hypersensitivity:** Temozolomide should not be used by individuals with known hypersensitivity to Temozolomide or dacarbazine.
* **Bone Marrow Suppression:** Temozolomide can significantly suppress bone marrow function, leading to low blood cell counts. Regular blood tests are necessary to monitor this.
* **Liver and Kidney Function:**  Patients with severe liver or kidney impairment should use Temozolomide with caution, and dosage adjustments might be necessary.
* **Pregnancy and Breastfeeding:** Temozolomide is categorized as pregnancy category D, meaning it poses a risk to the developing fetus. Women of childbearing age should use effective contraception during treatment. Breastfeeding is not recommended during treatment and for at least a week afterward.
* **Drug Interactions:** Temozolomide can interact with other medications, including live vaccines.  Inform your doctor about all medications, supplements, and vaccines you are taking.
* **Other Precautions:** Individuals receiving Temozolomide should be monitored for signs of infection, liver damage, and other potential side effects.


### FAQs

* **Q: How should I store Temozolomide?**  A: Store Temozolomide at room temperature, away from moisture and direct sunlight. Always follow the storage instructions provided on the packaging.

* **Q: Can I drive while taking Temozolomide?** A:  Temozolomide can cause dizziness or fatigue.  It’s best to avoid driving or operating machinery if you feel drowsy or unwell.

* **Q: What should I do if I miss a dose?** A: Contact your doctor or healthcare provider immediately to determine the best course of action.  Do not double the dose to make up for a missed one.

* **Q: How long will I need to take Temozolomide?** A: The duration of treatment varies significantly depending on the type of cancer, its severity, your response to the medication, and the overall treatment plan.


**Disclaimer:** This information is intended for general knowledge and informational purposes only, and does not constitute medical advice.  Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment. The information provided here is a summary based on the provided text and may not be exhaustive.  Always refer to the original prescribing information for complete details.
